NCT01208831View on ClinicalTrials.gov

An East Asian Study of LDE225

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Advanced Solid Tumor CancersMedulloblastomaBasal Cell Carcinoma
Interventions
DRUG

LDE225

Trial Locations (4)

10048

Novartis Investigative Site, Taipei

Unknown

Novartis Investigative Site, Hong Kong

466-8560

Novartis Investigative Site, Nagoya

650-0017

Novartis Investigative Site, Kobe

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY